GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Days Inventory

Cleo Diagnostics (ASX:COV) Days Inventory : 0.00 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Cleo Diagnostics's Average Total Inventories for the six months ended in Dec. 2023 was A$0.00 Mil. Cleo Diagnostics's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.00 Mil.

The historical rank and industry rank for Cleo Diagnostics's Days Inventory or its related term are showing as below:

ASX:COV's Days Inventory is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 192.78
* Ranked among companies with meaningful Days Inventory only.

Cleo Diagnostics's Days Inventory stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Cleo Diagnostics Days Inventory Historical Data

The historical data trend for Cleo Diagnostics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Days Inventory Chart

Cleo Diagnostics Annual Data
Trend Jun23
Days Inventory
-

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
Days Inventory - - -

Competitive Comparison of Cleo Diagnostics's Days Inventory

For the Medical Devices subindustry, Cleo Diagnostics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleo Diagnostics's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Days Inventory falls into.



Cleo Diagnostics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cleo Diagnostics's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as

Days Inventory (A: Jun. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: . 20 ) + Total Inventories (A: Jun. 2023 )) / count ) / Cost of Goods Sold (A: Jun. 2023 )*Days in Period
=( ( + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Cleo Diagnostics's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleo Diagnostics  (ASX:COV) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cleo Diagnostics's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cleo Diagnostics's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Cleo Diagnostics Days Inventory Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleo Diagnostics (ASX:COV) Business Description

Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines